Background: Asthma is a frequently disabling and almost invariably distressing disease that has a high overall prevalence. Although relaxation techniques and hypnotherapeutic interventions have proven their effectiveness in numerous trials, relaxation therapies are still not recommended in treatment guidelines due to a lack of methodological quality in many of the trials. Therefore, this study aims to investigate the efficacy of the brief relaxation technique of functional relaxation (FR) and guided imagery (GI) in adult asthmatics in a randomized controlled trial. Methods: 64 patients with extrinsic bronchial asthma were treated over a 4-week period and assessed at baseline, after treatment and after 4 months, for follow-up. 16 patients completed FR, 14 GI, 15 both FR and GI (FR/GI) and 13 received a placebo relaxation technique as the control intervention (CI). The forced expiratory volume in the first second (FEV1) as well as the specific airway resistance (sRaw) were employed as primary outcome measures. Results: Participation in FR, GI and FR/GI led to increases in FEV1 (% predicted) of 7.6 ± 13.2, 3.3 ± 9.8, and 8.3 ± 21.0, respectively, as compared to –1.8 ± 11.1 in the CI group at the end of the therapy. After follow-up, the increases in FEV1 were 6.9 ± 10.3 in the FR group, 4.4 ± 7.3 in the GI and 4.5 ± 8.1 in the FR/GI, compared to –2.8 ± 9.2 in the CI. Improvements in sRaw (% predicted) were in keeping with the changes in FEV1 in all groups. Conclusions: Our study confirms a positive effect of FR on respiratory parameters and suggests a clinically relevant long-term benefit from FR as a nonpharmacological and complementary therapy treatment option.

1.
ECRHS: Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687–695.
2.
ISAAC: Worldwide variations in the prevalence of asthma symptoms. The International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998;12:315– 335.
3.
Eder W, Ege MJ, von Mutius E: The asthma epidemic. N Engl J Med 2006;355:2226–2235.
4.
Lahmann C, Loew T, Leiberich P, Nickel M, Pfeifer M: Psychosomatic medicine in pneumology (in German). Psychodyn Psychother 2005;4:106–114.
5.
Lehrer PM: Emotionally triggered asthma: a review of research literature and some hypotheses for self regulation therapies. Appl Psychophysiol Biofeedback 1998;23:13–41.
6.
Mathé AA, Knappe PH: Emotional and adrenal reactions to stress in bronchial asthma. Psychosom Med 1971;33:323–340.
7.
Aboussafy D, Campbell TS, Lavoie K, Aboud FE, Ditto B: Airflow and autonomic responses to stress and relaxation in asthma: the impact of stressor type. Int J Psychophysiol 2005;57:195–201.
8.
Leigh D, Groen J, Rees L, Wretmark G, Wolff HG: Reproducible psychogenic attacks of asthma. J Psychosom Res 1956;1:58–67.
9.
Steptoe A, Holmes R: Mood and pulmonary function in adult asthmatics: a pilot self-monitoring study. Br J Med Psychol 1985;58:87–94.
10.
Yorke J, Fleming SL, Shuldham C: Psychological interventions for adults with asthma: a systematic review. Respir Med 2007;101:1–14.
11.
Vamos M, Kolbe J: Psychological factors in severe chronic asthma. Aust NZ J Psychiatry 1999;33:538–544.
12.
Huntley A, White AR, Ernst E: Relaxation therapies for asthma: a systematic review. Thorax 2002;57:127–131.
13.
Nickel C, Lahmann C, Muehlbacher M, Pedrosa Gil F, Kaplan P, Buschmann W, Tritt K, Kettler C, Bachler E, Egger C, Anvar J, Fartacek R, Loew T, Rother W, Nickel M: Pregnant women with bronchial asthma benefit from progressive muscle relaxation: a randomized, prospective, controlled trial. Psychother Psychosom 2006;75:237–243.
14.
Ewer OC, Stewart DE: Improvement in bronchial hyper-responsiveness in patients with moderate asthma after treatment with a hypnotic technique: a randomised controlled trial. BMJ 1986;293:1129–1132.
15.
Henry M, de Rivera JLG, Gonzalez-Martin IJ, et al: Improvement of respiratory function in chronic asthmatic patients with autogenic therapy. J Psychosom Res 1992;17:265–270.
16.
Coen BL, Philip B, McGrady A, et al: Effects of biofeedback-assisted relaxation on asthma severity and immune function. Pediatr Asthma Allergy Immunol 1996;10:71–78.
17.
Manocha R, Marks GB, Kenchington P, Peters D, Salome CM: Sahaja yoga in the management of moderate to severe asthma: a randomised controlled trial. Thorax 2002;57:110–115.
18.
Brown D: Evidence-based hypnotherapy for asthma. A critical review. Int J Clin Exp Hypn 2007;55:220–249.
19.
Freeman LW, Welton D: Effects of imagery, critical thinking, and asthma education on symptoms and mood state in adult asthma patients: a pilot study. J Altern Complement Med 2005;11:57–68.
20.
Loew T, Siegfried W, Martus P, Tritt K, Hahn EG: Functional relaxation reduces acute airway obstruction in asthmatics as effectively as inhaled terbutaline. Psychother Psychosom 1996;65:124–128.
21.
Loew TH, Tritt K, Siegfried W, Bohmann H, Martus P, Hahn EG: Efficacy of ‘functional relaxation’ in comparison to terbutaline and a ‘placebo relaxation’ method in patients with acute asthma. A randomized, prospective, placebo-controlled, crossover experimental investigation. Psychother Psychosom 2001;70:151–157.
22.
Moher D, Schulz KF, Altman DG, the Consort Group: The Consort statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–1194.
23.
Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. 2006. www.ginasthma.org.
24.
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Eur Respir J Suppl 1993;16:5–40.
25.
Lahmann C, Loew TH, Tritt K, Nickel M: Efficacy of functional relaxation and patient education in the treatment of somatoform heart disorders: a randomized, controlled clinical investigation. Psychosomatics 2008;49:378–385.
26.
Lahmann C, Schoen R, Henningsen P, Ronel J, Muehlbacher M, Loew T, Tritt K, Nickel M, Doering S: Brief relaxation versus music distraction in the treatment of dental anxiety. A randomized controlled clinical trial. J Am Dent Assoc 2008;139:317–324.
27.
Arnim A: Functional relaxation – psychotherapeutic tutorial. Fundamenta Psychiatrica 1994;8:196–203.
28.
Loew TH, Sohn R, Martus P, Tritt K, Rechlin T: Functional relaxation as a somatopsychotherapeutic intervention: a prospective controlled study. Altern Ther Health Med 2000;6:70–75.
29.
Rietveld S, Everaerd W, van Beest I: Excessive breathlessness through emotional imagery in asthma. Behav Res Ther 2000;38:1005–1014.
30.
Castés M, Hagel I, Palenque M, Canelones P, Corao A, Lynch NR: Immunological changes associated with clinical improvement of asthmatic children subjected to psychosocial intervention. Brain Behav Immun 1999;13:1–13.
31.
Lolak S, Connors GL, Sheridan MJ, Wise TN: Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom 2008;77:119–125.
32.
Hahn RA: The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med 1997;26:607–611.
33.
Geers AL, Kosbab K, Helfer SG, Weiland PE, Wellman JA: Further evidence for individual differences in placebo responding: an interactionist perspective. J Psychosom Res 2007;62:563–570.
34.
Carranza Rosenzweig JR, Edwards L, Lincourt W, Dorinsky P, Zu Wallack RL: The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respir Med 2004;98:1157–1165.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.